BioDiem Ltd - Company Profile
Powered by 
All the data and insights you need on BioDiem Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date BioDiem Ltd Strategy Report
- Understand BioDiem Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
BioDiem Ltd (BioDiem) is a biotechnology company that focuses on developing and commercializing vaccines and infectious disease therapies. It develops vaccines and novel therapeutic candidates for the treatment of seasonal and pandemic antimicrobial, influenza, and antifungal, and retinal diseases. The company’s product portfolio includes Live Attenuated Influenza Virus (LAIV) vaccine technology used to produce seasonal and pandemic influenza vaccines and antimicrobial BDM-I for the treatment of serious human infections. BioDiem partners with other vaccine and infectious disease treatment companies by licensing its LAIV vaccine and other technologies. The LAIV is licensed to World Health Organisation as part of the Global Pandemic Influenza Action Plan. BioDiem is headquartered in South Melbourne, Victoria, Australia.
Headquarters
Australia
Address
Level 4, 100 Albert Road, South Melbourne, Victoria, 3205
Website
www.biodiem.com
Telephone
61 3 96927240
Industry
Pharmaceuticals and Healthcare
Revenue (2022)
$279,500
BioDiem Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Nasovac-S: | Nasovac-S |
| Influenza Seasonal | |
| Technology: | |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | BioDiem Ltd | AdAlta Ltd | SciSparc Ltd | GlaxoSmithKline Australia Pty Ltd |
|---|---|---|---|---|
| Headquarters | Australia | Australia | Israel | Australia |
| City | South Melbourne | Melbourne | Tel Aviv-Yafo | Melbourne |
| State/Province | Victoria | Victoria | - | Victoria |
| No. of Employees | - | - | 3 | - |
| Entity Type | Private | Public | Public | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Damien Hannes | Chairman | Executive Board | 2022 | - |
| Julie Phillips | Director; Chief Executive Officer | Executive Board | 2010 | - |
| Melanie Leydin | Secretary; Chief Financial Officer | Senior Management | - | - |
| Fergus Mak Po Kan | Director | Non Executive Board | 2021 | - |
| Larisa Rudenko | Director | Non Executive Board | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer